By
Brenton Flynn
|
More Articles
November 7, 2012
|
MAKO Surgical (Nasdaq: MAKO ) , an up-and-comer in the robotic surgery arena, has had its fair share of stumbles recently. The company reports third-quarter results after the market closes, and investors will be focusing in on two major statistics. Follow along in the video below as Brenton Flynn runs through what they are and why they are so crucial to the MAKO story.
The recent market sell-off of MAKO Surgical shares has many wondering whether the company's potential growth prospects make this stock a buy or a stock to stay away from. To answer this question, Fool.com analyst and MAKO expert David Meier has authored a premium research report covering all of the must-know details on the company, including key areas to watch and risks looming in the future. As an added bonus, David will keep you informed with a full year of updates and guidance on MAKO as news breaks. Click here now to learn more and start reading.